TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary
Here's Where To Buy Legal Weed While Getting A Tattoo And A Beer: New Cannabis Stores In US And More
It seems that Big Alcohol is not seeing Big Marijuana as a threat, but rather a profitable opportunity. Moves made by some top companies such as Molson Coors, Anheuser-Busch (NYSE:BUD) and Constellati
TerrAscend Opens 20th Michigan Dispensary
TerrAscend to Engage in Major May Conferences
TerrAscend Announces May Conference Participation
TerrAscend First Quarter 2024 Earnings: EPS Misses Expectations
TerrAscend | 10-Q: Quarterly report
TerrAscend's Q1 2024: Revenue and EBITDA Climb
Earnings Flash (TSND) TERRASCEND Posts Q1 Revenue $80.6M
04:19 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (TSND) TERRASCEND Posts Q1 Revenue $80.6M
TerrAscend Brief: Q1 Net Revenue of US$80.6 Million, an Increase of 16.1% Year-over-year; Cash Flow From Operations of $13.3 Million and Free Cash Flow of $10.5 Million in the Quarter
04:17 PM EDT, 05/09/2024 (MT Newswires) -- TerrAscend Brief: Q1 Net Revenue of US$80.6 million, an increase of 16.1% year-over-year; Cash Flow from operations of $13.3 million and Free Cash Flow of $1
TerrAscend 2Q Loss/Shr 6c >TSND.T
TerrAscend 2Q Loss/Shr 6c >TSND.T
TerrAscend Debuts Legend Mini Pre-Rolls in NJ
Sometimes Legends Come in Small Packages
TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX:TSND) (OTCQX:TSNDF), a leading North American cannabis company, today announced that Legend, a cannabis
Cannabis Chart Of The Week: How Much Have MSO Valuation Multiples Changed In The Last Year And Why?
Most cannabis industry observers realize that valuations and valuations multiples for the major MSOs are up Y/O/Y, spurred by the promise of rescheduling. The chart shows the Enterprise Value to Cons
FDA Chief Sees No Reason for Delay in Cannabis Rescheduling
Amid an ongoing review by the Drug Enforcement Administration (DEA) to reschedule marijuana from a high-risk to a low-risk category, the head of the U.S. Food and Drug Administration (FDA), Robert Califf, said Thursday that there's "no reason" for the DEA to delay its decision.
Terrascend Corp Price Target Raised to C$6.60/Share From C$6.10 by Jefferies & Co
Terrascend Corp Price Target Raised to C$6.60/Share From C$6.10 by Jefferies & Co
Cannabis Rally Sparks Concerns Amid Moves to Mainstream
Pot stocks have bounced back from recent lows as investors await favorable regulatory changes in the U.S., while others have raised concerns of a sharp reversal if upcoming catalysts fail to materialize.
Trulieve-led Florida Adult-use Cannabis Campaign Gathers Steam
TerrAscend to Host First Quarter 2024 Earnings Conference Call
TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX:TSND) (OTCQX:TSNDF), a leading North American cannabis company, today announced that it will host a
Cannabis Measure to Enter Florida Ballot After Court Ruling
No Data